<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02616991</url>
  </required_header>
  <id_info>
    <org_study_id>2015-002741-64</org_study_id>
    <secondary_id>2015-A01262-47</secondary_id>
    <nct_id>NCT02616991</nct_id>
  </id_info>
  <brief_title>Computed Tomography CT Venography During Postpartum Venous Thromboembolism</brief_title>
  <acronym>CTVENPOSTPART</acronym>
  <official_title>Contribution of CT Venography for Diagnosing Venous Thromboembolism During Postpartum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether systematically performing computed&#xD;
      tomography (CT) venography (i.e a CT acquisition of the pelvis and of the lower limbs, during&#xD;
      the venous phase of opacification) in addition to thoracic CT angiography in women with&#xD;
      suspected postpartum pulmonary embolism (PE) results in a gain in venous thromboembolism&#xD;
      detection rate.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pulmonary embolism (PE) remains a leading cause of maternal death during postpartum in&#xD;
      developed countries; Thoracic computed tomography angiography (CTA) is the first-line&#xD;
      diagnostic test for PE suspicion, but has a 20 to 35% rate of inconclusiveness during&#xD;
      pregnancy and postpartum, 2 to 3 times higher than that of the general population. CT&#xD;
      venography (CTV) consists in a delayed CT acquisition of the abdomen, pelvis and lower limbs,&#xD;
      3 minutes after starting contrast administration. It can be used for detecting deep venous&#xD;
      thrombosis (DVT), the source of emboli in most PEs. The investigators hypothesized most&#xD;
      postpartum PEs are due to pelvic vein thrombosis and that detecting such pelvic DVT by&#xD;
      performing systematic CTV could increase the overall venous thromboembolism (VTE) detection.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 4, 2016</start_date>
  <completion_date type="Actual">April 2, 2021</completion_date>
  <primary_completion_date type="Actual">December 4, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of detected venous thromboembolism (VTE) based on Computed Tomography Angiography (CTA) plus Computed Tomography Venography (CTV)</measure>
    <time_frame>one day</time_frame>
    <description>VTE detection rate for readings based on CTA plus CTV as compared to readings based on CTA alone</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiation doses due to CT venography</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>kappa coefficients assessing inter-readers agreement for CT venography readings</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">125</enrollment>
  <condition>Pulmonary Thromboembolism</condition>
  <arm_group>
    <arm_group_label>Cohort</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>computed tomography venography</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>computed tomography venography</intervention_name>
    <description>systematically performing computed tomography venography in addition to thoracic computed tomography angiography</description>
    <arm_group_label>Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women with clinically suspected pulmonary embolism (PE) during the first 6 weeks&#xD;
             postpartum, without any sign of severe PE (shock, hypotension), referred for CT&#xD;
             angiography&#xD;
&#xD;
          -  Absence of contraindication to iodinated contrast medium injection (Previous allergic&#xD;
             reaction to iodinated contrast medium, renal insufficiency with creatine clearance&#xD;
             less than 30mL/mn, uncontrolled hyperthyroidism)&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Health insurance&#xD;
&#xD;
          -  Possibility to have 3-month follow-up&#xD;
&#xD;
          -  Obtention of written informed consent (ability to give consent)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Anticoagulation at therapeutic dosage for another reason than the suspicion of PE for&#xD;
             more than 72 hours&#xD;
&#xD;
          -  New pregnancy (In case of any doubt after medical history review, βHCG blood test must&#xD;
             be realized to ensure patient's pregnancy status)&#xD;
&#xD;
          -  Contrast medium extravasation during injection&#xD;
&#xD;
          -  CTA or CTV not performed according to the study requirements&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Pierre REVEL, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guy MEYER, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Paris 5 - Rene Descartes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cochin Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Revel MP, Sanchez O, Dechoux S, Couchon S, Frija G, Cazejust J, Chatellier G, Meyer G. Contribution of indirect computed tomographic venography to the diagnosis of postpartum venous thromboembolism. J Thromb Haemost. 2008 Sep;6(9):1478-81. doi: 10.1111/j.1538-7836.2008.03078.x. Epub 2008 Jul 8.</citation>
    <PMID>18627442</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 25, 2015</study_first_submitted>
  <study_first_submitted_qc>November 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2015</study_first_posted>
  <last_update_submitted>April 30, 2021</last_update_submitted>
  <last_update_submitted_qc>April 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

